Evergreen Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.04M | Buy |
6,059
+2,651
| +78% | +$1.27M | 0.05% | 271 |
|
|
2026
Q1 | $1.68M | Sell |
3,408
-493
| -13% | -$268K | 0.04% | 354 |
|
|
2025
Q4 | $2.26M | Buy |
3,901
+228
| +6% | +$129K | 0.05% | 283 |
|
|
2025
Q3 | $1.78M | Buy |
3,673
+899
| +32% | +$418K | 0.04% | 303 |
|
|
2025
Q2 | $1.13M | Sell |
2,774
-201
| -7% | -$84K | 0.03% | 344 |
|
|
2025
Q1 | $1.48M | Sell |
2,975
-49
| -2% | -$26.5K | 0.05% | 283 |
|
|
2024
Q4 | $1.57M | Sell |
3,024
-93
| -3% | -$51.1K | 0.05% | 286 |
|
|
2024
Q3 | $1.93M | Buy |
3,117
+152
| +5% | +$90K | 0.06% | 253 |
|
|
2024
Q2 | $1.64M | Buy |
2,965
+219
| +8% | +$125K | 0.06% | 257 |
|
|
2024
Q1 | $1.6M | Buy |
2,746
+155
| +6% | +$87K | 0.06% | 249 |
|
|
2023
Q4 | $1.38M | Sell |
2,591
-134
| -5% | -$64.9K | 0.06% | 262 |
|
|
2023
Q3 | $1.38M | Buy |
2,725
+108
| +4% | +$57.5K | 0.06% | 250 |
|
|
2023
Q2 | $1.37M | Sell |
2,617
-35
| -1% | -$18.9K | 0.06% | 251 |
|
|
2023
Q1 | $1.53M | Sell |
2,652
-213
| -7% | -$120K | 0.07% | 240 |
|
|
2022
Q4 | $1.58M | Buy |
2,865
+73
| +3% | +$38.7K | 0.07% | 236 |
|
|
2022
Q3 | $1.42M | Buy |
2,792
+424
| +18% | +$237K | 0.07% | 230 |
|
|
2022
Q2 | $1.29M | Sell |
2,368
-113
| -5% | -$62.2K | 0.07% | 237 |
|
|
2022
Q1 | $1.47M | Sell |
2,481
-47
| -2% | -$27K | 0.06% | 248 |
|
|
2021
Q4 | $1.69M | Buy |
2,528
+82
| +3% | +$51.2K | 0.07% | 232 |
|
|
2021
Q3 | $1.4M | Buy |
2,446
+509
| +26% | +$279K | 0.06% | 246 |
|
|
2021
Q2 | $977K | Buy |
1,937
+373
| +24% | +$176K | 0.05% | 267 |
|
|
2021
Q1 | $714K | Buy |
1,564
+154
| +11% | +$73.5K | 0.04% | 286 |
|
|
2020
Q4 | $657K | Buy |
1,410
+360
| +34% | +$169K | 0.04% | 260 |
|
|
2020
Q3 | $464K | Buy |
1,050
+39
| +4% | +$16.1K | 0.03% | 271 |
|
|
2020
Q2 | $366K | Sell |
1,011
-702
| -41% | -$235K | 0.03% | 277 |
|
|
2020
Q1 | $486K | Buy |
1,713
+33
| +2% | +$10.4K | 0.05% | 226 |
|
|
2019
Q4 | $546K | Hold |
1,680
| – | – | 0.05% | 237 |
|
|
2019
Q3 | $489K | Sell |
1,680
-150
| -8% | -$43K | 0.05% | 228 |
|
|
2019
Q2 | $537K | Buy |
1,830
+360
| +24% | +$99.2K | 0.05% | 223 |
|
|
2019
Q1 | $402K | Buy |
1,470
+65
| +5% | +$16.2K | 0.04% | 235 |
|
|
2018
Q4 | $314K | Sell |
1,405
-36
| -2% | -$8.45K | 0.03% | 260 |
|
|
2018
Q3 | $352K | Buy |
1,441
+49
| +4% | +$11.3K | 0.03% | 256 |
|
|
2018
Q2 | $288K | Buy |
1,392
+3
| +0.2% | +$637 | 0.03% | 283 |
|
|
2018
Q1 | $287K | Buy |
+1,389
| New | +$292K | 0.03% | 280 |
|
Other funds holding TMO
Evergreen Capital Management's TMO Position: Q2 2026 in Review
Evergreen Capital Management increased its Thermo Fisher Scientific (TMO) stake by 78% in Q2 2026, buying an estimated $1.27M and bringing the position to 6,059 shares worth $3.04M. The position accounts for 0.05% of the portfolio, ranked #271.
Evergreen Capital Management first reported a position in TMO in Q1 2018 and has held it in 34 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Evergreen Capital Management held 6,059 shares of Thermo Fisher Scientific worth $3.04M as of Q2 2026.
- Evergreen Capital Management bought 2,651 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.27M.
- Thermo Fisher Scientific made up 0.05% of Evergreen Capital Management's portfolio in Q2 2026, its #271 holding.
- Evergreen Capital Management first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 34 quarters since.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.